Concourse Financial Group Securities, Inc. Esperion Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

29 transactions

Quarter	Operation	Price Per share
Q2 2025 Aug 12, 2025	BUY	$0.73 - $1.41 $0 - $0
Q1 2025 May 14, 2025	BUY	$1.44 - $2.34 $0 - $0
Q4 2024 Feb 13, 2025	BUY	$1.61 - $3.83 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$1.61 - $2.73 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$1.84 - $3.24 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$2.02 - $3.02 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.73 - $3.08 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.96 - $1.79 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.96 - $1.79 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.2 - $1.76 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$5.09 - $8.5 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$5.45 - $8.13 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$4.77 - $6.67 $0 - $0
Q1 2022 May 09, 2022	BUY	$3.34 - $5.56 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$4.81 - $11.92 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$11.34 - $21.37 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$19.4 - $28.71 $0 - $0
Q1 2021 May 13, 2021	BUY	$25.12 - $36.89 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$24.2 - $35.76 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$31.18 - $52.71 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$30.04 - $51.31 $0 - $0
Q1 2020 May 13, 2020	BUY	$27.44 - $73.84 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$34.47 - $47.53 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$40.1 - $52.33 $0 - $0
Q1 2019 May 15, 2019	BUY	$40.11 - $53.57 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$40.74 - $51.41 $0 - $0

Others Institutions Holding ESPR

# of Institutions

184

Shares Held

108M

Call Options Held

139K

Put Options Held

604K

Black Rock Inc. New York, NY

14M
Shares

$36.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

12.1M
Shares

$31.9 Million
0.0% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

10.3M
Shares

$27.3 Million
0.05% of portfolio
Two Seas Capital LP Rye, NY

9.95M
Shares

$26.3 Million
0.18% of portfolio
Pender Fund Capital Management Ltd. Vancouver, A1

6.68M
Shares

$17.6 Million
4.26% of portfolio

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $176M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account